Sweet move: A modified sugar enhances antisense oligonucleotide safety and efficacy for treating CNS disease
Researchers have found that a newly developed modified sugar increases the efficacy and safety of antisense oligonucleotides designed to treat central nervous system disease.
May 22, 2024
0
14